For research use only. Not for use in humans.

Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE)

Synonyms: GC33 Cat.No.D4061 Purity:99%

Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) is an antibody-drug conjugate (ADC) targeting GPC3 (glypican-3). It induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth and can be used in the research of hepatocellular carcinoma (HCC). MW :145.58 KD.

Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE)

CAS No. 1365267-33-9

Quality Control

Batch: D406101 Purity: 99% Protein concentration: 8.583mg/ml Endotoxin Level: ＜1EU/mg

99

Mechanism of Action

Description	Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) is an antibody-drug conjugate (ADC) targeting GPC3 (glypican-3). It induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth and can be used in the research of hepatocellular carcinoma (HCC). MW :145.58 KD.
References	[1] https://aacrjournals.org/cancerres/article/78/13_Supplement/2747/627053/Abstract-2747-Anti-glypican-3-monoclonal-antibody

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	1365267-33-9
Molecular Weight	145.58
Formulation	100 mM Pro-Ac, 20mM Arg, pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.